PBM EnvisionRx chooses Gilead hepatitis C drugs for its formulary
January 26, 2015 at 14:39 PM EST
Jan 26 (Reuters) - Pharmacy benefits manager EnvisionRx said on Monday it reached an agreement to provide its customers with Gilead Sciences Inc's hepatitis C drugs on an exclusive basis, the latest Gilead victory in a market share battle with AbbVie over their new treatments for the liver destroying virus.